To understand how an organization functions, you must analyze its dynamics and performance. The benefit of using a congruence model for this analysis is that it divides the analysis into four parts ...
MONTREAL, April 20, 2026 /PRNewswire/ -- Congruence Therapeutics, a clinical-stage, computationally-driven biotechnology company building a unique pipeline of pharmacological correctors for diseases ...
The congruence model for a business is a change management process that examines the performance of an organization based on how it operates as a system. It was developped in the 1980s by ...
Expanded collaboration continues to leverage Congruence's proprietary computational drug discovery engine, Revenir™ to deliver Development Candidates in Neurology and Immunology Congruence to receive ...
Congruence Therapeutics, a clinical-stage, computationally-driven biotechnology company building a unique pipeline of pharmacological correctors for diseases of protein misfolding, including ...
Congruence pulls in $50M series A to build a team of 'drug hunters' to go after rare disease targets
A new biotech called Congruence Therapeutics snagged $50 million to build a new team of "drug hunters" focused on protein misfolding to go after rare diseases. Congruence Therapeutics just completed a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results